Fully assessing children’s sleep environments and effectively promoting children’s overall sleep health is nearly impossible during brief clinical encounters.
AMA J Ethics. 2024;26(10):E755-762. doi:
10.1001/amajethics.2024.755.
Historically, most discussions about nonhuman animal experimentation consider what has become known as the 3 R’s: refinement, reduction, and replacement.
AMA J Ethics. 2024;26(9):E701-708. doi:
10.1001/amajethics.2024.701.
Ethically justifying human-centered research with only nonhuman animals as subjects likely requires that the research’s benefits to humans must, at least, outweigh harms suffered by the nonhuman animals.
AMA J Ethics. 2024;26(9):E673-678. doi:
10.1001/amajethics.2024.673.
Dr David DeGrazia joins Ethics Talk to discuss why the “3 R’s” of nonhuman animal research might not be sufficient to promote good science, ethics, and nonhuman animal welfare.
Theodore E. Schall, PhD, MSW, MBE, Kaitlyn Jaffe, PhD, and Jacob D. Moses, PhD
Clinicians should know how randomized controlled trials can and cannot contribute to advancing health equity for transgender and gender diverse people.
AMA J Ethics. 2024;26(9):E684-689. doi:
10.1001/amajethics.2024.684.
Adrienne W. Henize, JD and Andrew F. Beck, MD, MPH
Data on certain chronic conditions’ prevalence, incidence of potentially preventable morbidity, and health-harming legal factors influence approaches to care.
AMA J Ethics. 2024;26(8):E648-654. doi:
10.1001/amajethics.2024.648.